Art TherapyNCT07398196
Effects of Art Therapy on Symptoms and Spiritual Well-Being in Hemodialysis
A study testing art therapy in people with Art Therapy, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
Hemodialysis patients are confronted with a wide range of symptoms that adversely affect their daily functioning. Nurses hold a pivotal role in assessing these symptoms and their consequences, and in implementing evidence-based interventions aimed at enhancing patient well-being. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Art Therapy
- What is being tested?
- art therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2022to 1 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- undergoing hemodialysis treatment
- volunteering to participate in the study
- fluency in Turkish
- mental competence
- the ability to use their hands effectively
Who cannot join
- Five non-Turkish-speaking foreign patients
- 15 patients were excluded due to lack of voluntary participation
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kütahya Health Sciences University Evliya Çelebi Training and Research Hospital
Kütahya
About this study
Official title: The Effect of Art Therapy Applied During Hemodialysis on Dialysis Symptoms and Spiritual Well-Being: A Randomised Controlled Study
Hemodialysis patients are confronted with a wide range of symptoms that adversely affect their daily functioning. Nurses hold a pivotal role in assessing these symptoms and their consequences, and in implementing evidence-based interventions aimed at enhancing patient well-being. This study designed to examine the effect of art therapy administered during hemodialysis on dialysis-related symptoms and spiritual well-being. This study aims to reduce hemodialysis symptoms and enhance spiritual well-being in patients undergoing hemodialysis by diverting their attention through non-invasive, non-pharmacological interventions such as art therapy. Art therapy is a type of therapy designed to connect patients to life, facilitate their integration into society, and increase their self-respect and self-confidence by developing their skills. Art therapy practices increase a person's mental well-being by reducing anxiety and stress. Studies using art therapy have found that both patients and their caregivers experience an increase in quality of life. However, there are no studies in the literature examining the symptoms experienced by patients during hemodialysis and their effect on spiritual well-being. The research will be conducted on patients undergoing hemodialysis treatment, and patients in the experimental group will receive at least 30 minutes of art therapy during each dialysis session. Data obtained before the start of the study, after 4 weeks of application, and 4 weeks after the end of the application will be compared with the control group data. In addition to its scientific contribution, it is thought that effective symptom management may contribute to the well-being of patients.
- Conditions
- Art Therapy
- Being tested
- art therapy
- Keywords
- hemodialysis, dialysis symptoms, spirituality, nursing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
art therapyOther
Art Therapy
| Study group | Role | What they receive |
|---|---|---|
| Art Therapy | Experimental | Patients undergoing hemodialysis treatment participated in art therapy sessions three times a week for four weeks during their hemodialysis treatment. Receives: Other: art therapy |
| Control Group | No intervention | Patients in this group did not undergo any intervention and received standard treatment and care during hemodialysis. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dialysis Syptoms
The Dialysis Symptom Inventory (DSI) was used, validated and tested for reliability in Turkish by Önsöz and Usta Yeşilbalkan (2013) based on Weisbord et al. (2004). Test scores ranged from 30 to 150, with higher scores indicating more prevalent and stronger symptoms.
Measured: The scale was administered at baseline, 4 weeks post-intervention, and 8 weeks post-intervention.
Spiritual Well-Being
The Spiritual Well-Being (SWB) Scale, developed by Breedle and colleagues (2011) and validated and reliability tested in Turkish by Ekşi and Kardaş (2017), was used. It is a five-point Likert-type scale consisting of 12 items. The score obtained from the spiritual well-being scale ranges from 0 to 48. A higher score indicates that patients have a high level of spiritual well-being.
Measured: The scale was administered at baseline, 4 weeks post-intervention, and 8 weeks post-intervention.
Secondary outcomes (1)
Patient Satisfaction
The patient satisfaction form for art therapy, developed by the researchers, consists of 8 items. The form includes questions regarding prior participation in art therapy activities and patients' perceptions of the researcher's conduct during the intervention. In the last question of this form, patients were asked to rate their satisfaction level on a scale of 0-10. A high score indicates high satisfaction.
Measured: The form was administered 4 weeks post-intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2026
- Study start1 Nov 2022
- Primary completion1 Apr 2023
- Study completion1 Jun 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Art TherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Seda Pehlivan, Uludag University
- Investigators
- Seda Pehlivan, Associate Professor, Principal investigator, Bursa Uludağ Üniversitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07398196
- Sponsor's protocol ID
- 887076
- Status last verified
- Sep 2022
- First submitted
- 2 Feb 2026
- Last updated
- 12 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Art Therapy Applied During Hemodialysis on Dialysis Symptoms and Spiritual Well-Being: A Randomised Controlled Study
- ClinicalTrials.gov ID
- NCT07398196
- Acronym / sponsor ID
- 887076
- Conditions
- Art Therapy
- Keywords
- hemodialysis, dialysis symptoms, spirituality, nursing
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 1 Nov 2022 (actual)
- Primary completion
- 1 Apr 2023 (actual)
- Study completion
- 1 Jun 2023 (actual)
- First posted
- 9 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hemodialysis patients are confronted with a wide range of symptoms that adversely affect their daily functioning. Nurses hold a pivotal role in assessing these symptoms and their consequences, and in implementing evidence-based interventions aimed at enhancing patient well-being. This study designed to examine the effect of art therapy administered during hemodialysis on dialysis-related symptoms and spiritual well-being. This study aims to reduce hemodialysis symptoms and enhance spiritual well-being in patients undergoing hemodialysis by diverting their attention through non-invasive, non-pharmacological interventions such as art therapy. Art therapy is a type of therapy designed to connect patients to life, facilitate their integration into society, and increase their self-respect and self-confidence by developing their skills. Art therapy practices increase a person's mental well-being by reducing anxiety and stress. Studies using art therapy have found that both patients and their caregivers experience an increase in quality of life. However, there are no studies in the literature examining the symptoms experienced by patients during hemodialysis and their effect on spiritual well-being. The research will be conducted on patients undergoing hemodialysis treatment, and patients in the experimental group will receive at least 30 minutes of art therapy during each dialysis session. Data obtained before the start of the study, after 4 weeks of application, and 4 weeks after the end of the application will be compared with the control group data. In addition to its scientific contribution, it is thought that effective symptom management may contribute to the well-being of patients.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Art Therapy | Experimental | Other: art therapyPatients undergoing hemodialysis treatment participated in art therapy sessions three times a week for four weeks during their hemodialysis treatment. |
| Control Group | No intervention | –Patients in this group did not undergo any intervention and received standard treatment and care during hemodialysis. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- undergoing hemodialysis treatment
- volunteering to participate in the study
- fluency in Turkish
- mental competence
- the ability to use their hands effectively
Key exclusion criteria (2 listed)
- Five non-Turkish-speaking foreign patients
- 15 patients were excluded due to lack of voluntary participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| art therapyArt Therapy | Other | Art Therapy |
Primary outcome
Dialysis Syptoms
Time frame: The scale was administered at baseline, 4 weeks post-intervention, and 8 weeks post-intervention.
The Dialysis Symptom Inventory (DSI) was used, validated and tested for reliability in Turkish by Önsöz and Usta Yeşilbalkan (2013) based on Weisbord et al. (2004). Test scores ranged from 30 to 150, with higher scores indicating more prevalent and stronger symptoms.
Spiritual Well-Being
Time frame: The scale was administered at baseline, 4 weeks post-intervention, and 8 weeks post-intervention.
The Spiritual Well-Being (SWB) Scale, developed by Breedle and colleagues (2011) and validated and reliability tested in Turkish by Ekşi and Kardaş (2017), was used. It is a five-point Likert-type scale consisting of 12 items. The score obtained from the spiritual well-being scale ranges from 0 to 48. A higher score indicates that patients have a high level of spiritual well-being.
1 secondary outcome
Patient Satisfaction
Time frame: The form was administered 4 weeks post-intervention.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Art Therapy
Recruiting
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
HIV, HIV Treatment
Enrolling by invitation
Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
Pregnant HIV Positive Women
RecruitingObservational study
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
HIV
Active, not recruitingPhase 2
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression
HIV, Heavy Drinking
Not yet recruiting
Expressive Arts Therapy in Major Depression: An RCT
Depression - Major Depressive Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Seda Pehlivan, Associate Professor principal investigator
Bursa Uludağ Üniversitesi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing art therapy in people with Art Therapy, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dialysis Syptoms (time frame: The scale was administered at baseline, 4 weeks post-intervention, and 8 weeks post-intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2026.